You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

PYRIDOXINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pyridoxine Hydrochloride patents expire, and when can generic versions of Pyridoxine Hydrochloride launch?

Pyridoxine Hydrochloride is a drug marketed by Bel Mar, Dell Labs, Dr Reddys, Elkins Sinn, Epic Pharma Llc, Fresenius Kabi Usa, Luitpold, Mylan Institutional, and Watson Labs. and is included in ten NDAs.

The generic ingredient in PYRIDOXINE HYDROCHLORIDE is pyridoxine hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pyridoxine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pyridoxine Hydrochloride

A generic version of PYRIDOXINE HYDROCHLORIDE was approved as pyridoxine hydrochloride by FRESENIUS KABI USA on December 31st, 1969.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PYRIDOXINE HYDROCHLORIDE?
  • What are the global sales for PYRIDOXINE HYDROCHLORIDE?
  • What is Average Wholesale Price for PYRIDOXINE HYDROCHLORIDE?
Drug patent expirations by year for PYRIDOXINE HYDROCHLORIDE
Recent Clinical Trials for PYRIDOXINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bahria UniversityNA
Innovative Medicines InitiativePHASE2
TASK Applied SciencePHASE2

See all PYRIDOXINE HYDROCHLORIDE clinical trials

Pharmacology for PYRIDOXINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PYRIDOXINE HYDROCHLORIDE

US Patents and Regulatory Information for PYRIDOXINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bel Mar PYRIDOXINE HYDROCHLORIDE pyridoxine hydrochloride INJECTABLE;INJECTION 080761-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa PYRIDOXINE HYDROCHLORIDE pyridoxine hydrochloride INJECTABLE;INJECTION 080618-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Dr Reddys PYRIDOXINE HYDROCHLORIDE pyridoxine hydrochloride INJECTABLE;INJECTION 080572-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Luitpold PYRIDOXINE HYDROCHLORIDE pyridoxine hydrochloride INJECTABLE;INJECTION 080669-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Pyridoxine Hydrochloride

Last updated: December 28, 2025

Executive Summary

Pyridoxine Hydrochloride (Vitamin B6) is a vital nutrient used extensively within pharmaceuticals, dietary supplements, and fortification markets globally. Its broad application spectrum, coupled with rising health consciousness and increasing prevalence of conditions such as anemia and neurological disorders, sustains robust demand growth. This analysis explores the current market landscape, key drivers, challenges, opportunities, and financial trajectories shaping the future of Pyridoxine Hydrochloride. It also provides insights into competitive dynamics, regulatory frameworks, and strategic considerations vital for stakeholders.


1. Introduction: What Is Pyridoxine Hydrochloride?

Pyridoxine Hydrochloride is a water-soluble vitamin (Vitamin B6) critical for amino acid metabolism, neurotransmitter synthesis, hemoglobin production, and immune function. Recognized as an essential nutrient, it is dispensed as a standalone supplement and incorporated into multiple multivitamin formulations.

Chemical Profile

Parameter Details
Chemical Name Pyridoxine Hydrochloride
CAS Number 51-83-2
Molecular Formula C8H11NO3·HCl
Molecular Weight 205.65 g/mol

Market Application Sectors:

  • Pharmaceuticals (therapeutic formulations)
  • Dietary Supplements (OTC products)
  • Food Fortification
  • Animal Nutrition

2. Market Drivers: What Is Propelling Growth?

a. Rising Prevalence of Deficiencies and Health Conditions

  • Vitamin B6 Deficiency: Increasing global prevalence due to malnutrition, particularly in developing nations.
  • Neurological Disorders: Growing awareness and diagnosis of conditions like peripheral neuropathy and depression.
  • Anemia and Immune Support: Increased supplementation to support immune functions, especially post-pandemic.

b. Expanding Dietary Supplement Market

  • The global dietary supplements market is projected to reach USD 278.02 billion by 2024 at a CAGR of 7.4% (2020-2024) [1].
  • Vitamin B6, including Pyridoxine Hydrochloride, constitutes a significant share due to demand for immunity boosting and general health.

c. Pharmaceuticals and Fortification Trends

  • The incidence of chronic illnesses and metabolic disorders accelerates demand for pharmaceutical-grade Pyridoxine Hydrochloride.
  • Food fortification initiatives in countries like India and Nigeria enhance micronutrient intake, expanding market reach.

d. Regulatory and Policy Environment

  • WHO recommends adequate intake levels, promoting supplementation.
  • Regulatory classification (self-medication vs. prescription) varies by region, impacting market entry strategies.

3. Market Size and Forecast

a. Current Market Valuation

Region Estimated Market Size (USD Billion) Key Trends
North America ~$0.75 billion (2022) High supplement consumption, mature pharma
Europe ~$0.50 billion Strong food fortification policies
Asia-Pacific ~$1.0 billion Rapid urbanization, growing supplement use
Rest of World ~$0.25 billion Emerging markets, rising awareness

Total Global Market (2022): Approximately USD 2.5 billion.

b. Forecasts (2023-2028)

Year Predicted Market Size (USD Billion) CAGR
2023 ~$2.75 billion 10%
2024 ~$3.02 billion
2025 ~$3.31 billion 10%
2026 ~$3.64 billion
2027 ~$4.00 billion
2028 ~$4.40 billion 10%

Source: MarketResearchFuture, 2022 [2]


4. Competitive Landscape

a. Major Market Players

Company Market Share (%) Production Capacity Strategic Moves
DSM (Netherlands) 20% >10,000 MT/year Vertical integration, R&D investments
BASF (Germany) 15% >8,000 MT/year Capacity expansion, mergers
Zhejiang NHU Co., Ltd. 12% >5,000 MT/year Regional expansion
others 53% Varies Diversification, M&A

Major players leverage integrated supply chains and diversified product portfolios.

b. Production & Supply Flows

Aspect Details
Raw Materials Pyridoxine synthesized via chemical or microbial routes
Manufacturing Countries China (~60%), India, Europe, North America
Pricing Trends Declining due to oversupply; recent stabilization
Supply Chain Risks Raw material scarcity, geopolitical tensions

5. Market Challenges and Barriers

Challenge Impact
Regulatory Hurdles Variability impacts time-to-market and costs
Price Volatility Market oversupply leads to price fluctuations
Raw Material Availability Dependent on chemical feedstocks or microbial processes
Competition from Generics Market saturation limits profit margins

6. Future Opportunities

a. Innovation and Product Differentiation

  • Development of sustained-release and bioavailable formulations.
  • Integration into functional foods targeting specific demographics.

b. Emerging Markets

  • Significant growth potential in regions with rising health awareness.
  • Government initiatives promoting micronutrient fortification.

c. Strategic Alliances

  • Partnerships with pharma and nutraceutical companies.
  • Vertical integration to control raw material sourcing and distribution.

7. Regulatory and Policy Framework

Region Regulatory Authority Key Policies Implication for Market
USA FDA GRAS status, supplement standards Easier market access
EU EMA, EFSA Novel food regulations, fortification policies Stringent; compliance needed
China CFDA Food additive regulations, GMP standards Growing demand; strict oversight
India FSSAI Fortification mandates, supplement regulations Opportunities in fortification

8. Comparing Pyridoxine Hydrochloride to Other Forms of Vitamin B6

Feature Pyridoxine Hydrochloride Pyridoxal-5-phosphate (P5P) Pyridoxamine
Bioavailability High Higher Moderate
Stability Good Excellent Moderate
Cost Lower Higher Similar
Regulatory Status Widely accepted in supplements Generally recognized as active form Less common in market

Key Takeaways

  • Market Growth: The Pyridoxine Hydrochloride market is expected to grow at a CAGR of approximately 10% through 2028, driven by supplement demand and food fortification initiatives.
  • Major Drivers: Rising malnutrition, chronic disease prevalence, and governmental policies favoring micronutrient fortification.
  • Competitive Landscape: Dominated by DSM and BASF, with a fragmented but expanding supplier base, primarily in China and India.
  • Challenges: Regulatory complexities, raw material supply constraints, and price competition.
  • Opportunities: Innovation in delivery forms, strategic alliances, expanding into emerging markets, and leveraging regulatory support for fortification projects.
  • Regulatory Impact: Variations necessitate tailored compliance strategies; global harmonization efforts could streamline market entry.

FAQs

1. What factors influence Pyridoxine Hydrochloride prices?
Prices are affected by raw material costs, supply-demand imbalances, regulatory policies, and production efficiencies. Oversupply has historically driven prices down, but recent stabilization reflects healthier market dynamics.

2. Which regions exhibit the highest growth potential?
Asia-Pacific and Africa demonstrate significant growth due to expanding supplement markets and food fortification policies, coupled with rising health awareness.

3. How does regulatory variation affect market entry?
Differing standards for supplementation, food fortification, and pharmaceuticals impact approval timelines and costs, requiring region-specific strategies.

4. What are the key applications of Pyridoxine Hydrochloride?
Major applications include dietary supplements, prescription drugs for deficiency conditions, and as a functional ingredient in fortified foods.

5. How is innovation impacting the Pyridoxine Hydrochloride market?
Advancements in bioavailability, stability, and delivery mechanisms (e.g., sustained-release formulations) are creating new opportunities for manufacturer differentiation and expanded indications.


References

[1] Grand View Research, “Dietary Supplements Market Size & Trends,” 2020.
[2] MarketResearchFuture, “Vitamin B6 Market Analysis & Forecast,” 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.